Summary
The cardioprotective effects of an antilipolytic compound, nicotinic acid, on arrested-reperfused myocardium were investigated in the isolatedin situ pig heart preparation. Hearts were preperfused for 15 min in the presence of (5-3H)-glucose and (U-14C)-palmitic acid. Half of the hearts were then perfused with 0.08 mM nicotinic acid for an additional 15-min period, while the remaining control hearts received unmodified perfusion. Arrest was then induced in all animals for 2 h using hypothermic K+ cardioplegia, followed by 60 min of normothermic reperfusion. In control hearts, there were significantly greater levels of long-chain acyl Co-A and acyl carnitine and lower levels of membrane phospholipids than in the nicotinic acid group. While nicotinic acid inhibited β-oxidation during pre-ischemia and reperfusion, it also prevented the degradation of membrane phospholipids. The net result was a reduction of free fatty acid accumulation during arrest and reperfusion in the nicotinic acid group. Glycolysis, as reflected in3H2O production, was significantly increased by nicotinic acid administration. In the control heart as compared to the nicotinic acid group, the incorporation of14C-label from palmitate into triglyceride and cholesterol during arrest was enhanced, while incorporation into phospholipids was depressed. The cardioprotective effects of nicotinic acid were demonstrated by decreased release of creatine kinase and improved coronary blood flow, and cardiac contractility in the reperfused myocardium supplemented with nicotinic acid compared to the control group. These results suggest that nicotinic acid significantly protects the arrested-reperfused myocardium by a) preventing elevation of myocardial fatty acid levels, b) stimulating glycolysis by limiting fatty acid oxidation, c) inhibiting degradation of membrane phospholipids, and d) preventing accumulation of fatty acid metabolites with harmful detergent properties.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466–468
Brownsey RW, Brundt RV (1977) The effect of adrenaline-induced endogenous lipolysis upon the mechanical and metabolic performance of ischemically perfused rat hearts. Clin Sci Mol Med 53:13–21
Chien KR, Hans A, Sen A, Biya PLM, Willerson JT (1984) Accumulation of unesterified arachidonic acid in ischemic myocardium. Circ Res 54:313–322
Cordis G, Otani H, Engelman RM, Otani H, Das DK (1986) Accumulation of unesterified fatty acids in ischemic rat myocardium. Fed Proc 45:656
Corr PB, Gross RW, Sobel BE (1982) Arrhythmogenic amphiphilic lipids and the myocardial cell membrane. J Mol Cell Cardiol 14:619–626
Das DK, Ayromlooi J, Neogi A (1983) Effect of ischemia on fatty acid metabolism in fetal lung. Life Sci 33:569–576
Das DK, Engelman RM, Rousou JA, Breyer RA, Otani H, Lemeshow S (1986) Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol 251:H71-H79
Das DK, Steinberg H (1984) Effect of starvation and diabetes on glucose transport in the lung. Clin Physiol Biochem 2:239–248
Datta S, Otani H, Engelman RM, Breyer RH, Rousou JA, Jones R, Cordis G, Lemeshow S, Das DK (1986) Antilipolytic therapy: an effective intervention to protect the ischemic heart during open-heart surgery. Surg Forum 37:275–277
Engelman RM, Das DK, Otani H, Rousou JA, Breyer RH (1986) Retrograde coronary sinus cardioplegia-influence on fatty acid metabolism during myocardial ischemia. In: Proceedings of the 2nd International Symposium on Myocardial Protection via the Coronary Sinus; Steinkopff Verlag, Darmstadt, pp 215–220
Folch J, Lees M, Sloan-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509
Hamilton JG, Comai K (1984) Separation of neutral lipids and free fatty acids by high performance liquid chromatography using low wavelength ultraviolet detection. J Lipid Res 25:1142–1148
Katz AM, Messinco FC (1982) Fatty acid effects on membranes: possible role in the pathogenesis of ischemic myocardial damage. J Mol Cell Cardiol 14 (Suppl 3):1199–1220
Katz AM (1982) Membrane-derived lipids and the pathogenesis of ischemic myocardial damage. J Mol Cell Cardiol 14:627–632
Lopaschuk GD, Hansen CA, Neely JR (1986) Fatty acid metabolism in heart containing elevated levels of CoA. Am J Physiol 250:H351-H359
Mjos OD (1971) Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 50:1386–1389
Opie LH (1984) Substrate and energy metabolism of the heart. In: Sperelakis N (ed) Function of the heart in normal and pathological states; Martinus Nijhoff Publishers, New York, pp 301–336
Opie LH (1975) Metabolism of free fatty acids, glucose und catecholamines in acute myocardial infarction. Am J Cardiol 36:938–953
Opie LH, Owen P (1976) Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose and of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am J Cardiol 38:310–321
Otani H, Engelman RM, Breyer RH, Rousou JA, Lemeshow S, Das DK (1986) Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg 92:247–254
Otani H, Engelman RM, Rousou JA, Breyer RH, Lemeshow S, Das DK (1986) Cardiac performance during reperfusion improved by pretreatment with oxygen free radical scavengers. J Thorac Cardiovasc Surg 91:290–295
Otani H, Engelman RM, Rousou JA, Breyer RH, Das DK (1986) Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. J Mol Cell Cardiol 18:954–961
Probst O, Spahr R, Schweickhardt C, Hunneman DH, Piper HM (1986) Carbohydrate and fatty acid metabolism of cultured adult cardiac myocytes. Am J Physiol 250:H853-H860
Rousou JA, Engelman RM, Anismowicz L, Lemeshow S, Dobbs WA, Breyer RH, Das DK (1986) Metabolic enhancement of myocardial preservation during cardioplegic arrest. J Thorac Cardiovasc Surg 91:270–276
Rowe MJ, Neilson JMM, Oliver MF (1975) Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic acid analogue. Lancet 8:295–300
Russel DC, Oliver MF (1978) Effect of antilipolytic therapy on ST-segment elevation during myocardial ischemia in man. Br Heart J 40:117–123
Scheuer J, Brachfeld N (1966) Myocardial uptake and fractional distribution of palmitate [1-14C] by the ischemic dog heart. Metabolism 15:945–959
Sodi-Pallares D, Testell MR, Fishleder BL (1967) Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction: a preliminary clinical report. Am J Cardiol 9:166–181
Van der Vusse GJ, Roemen THM, Prinzen FW, Coumans WA, Reneman RS (1982) Uptake and tissue content of fatty acids in dog myocardium under normonic and ischemic conditions. Circ Res 50:538–546
Vik-Mo H (1977) Distribution of coronary blood flow during acute coronary occlusion in dogs: effect of nicotinic acid and sodium salicylate. Scand J Clin Lab Invest 37:697–703
Whitmer JT, Idell-Wenger JA, Rovetto MJ, Neely JR (1978) Control of fatty acid metabolism in ischemic and hypoxic hearts. J Biol Chem 253:4305–4309
Wood R, Lee T (1983) High performance liquid chromatography of fatty acids: quantitative analysis of saturated, monoenoic, polyenoic and geometrical isomers. J Chromatogr 254:237–246
Author information
Authors and Affiliations
Additional information
Supported by NIH Grants HL22559-06, HL33889 and HL34360, and American Heart Association Grant 11-202-856.
Rights and permissions
About this article
Cite this article
Datta, S., Das, D.K., Engelman, R.M. et al. Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound: Mechanism of action. Basic Res Cardiol 84, 63–76 (1989). https://doi.org/10.1007/BF01907004
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907004